Three-dimensional nuclear magnetic resonance spectroscopy: a complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0T.

Date publication

août 2021

Journal

Quantitative imaging in medicine and surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CORMIER Luc , Pr COCHET Alexandre , Pr LOFFROY Romaric

Tous les auteurs :
Deal M, Bardet F, Walker PM, de la Vega MF, Cochet A, Cormier L, Bentellis I, Loffroy R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34341747

Résumé

The limitations of the assessment of tumor aggressiveness by Prostate Imaging Reporting and Data System (PI-RADS) and biopsies suggest that the diagnostic algorithm could be improved by quantitative measurements in some chosen indications. We assessed the tumor high-risk predictive performance of 3.0 Tesla (3.0T) multiparametric magnetic resonance imaging (mp-MRI) combined with nuclear magnetic resonance spectroscopic sequences (NMR-S) in order to show that the metabolic analysis could bring out an evocative result for the aggressive form of prostate cancer.

Mots clés

1H magnetic resonance spectroscopic imaging (1H MRSI), Gleason, International Society of Urological Pathology (ISUP), Prostate Imaging Reporting and Data System (PI-RADS), Prostate cancer, intermediate risks, magnetic resonance imaging (MRI), spectroscopy

Référence

Quant Imaging Med Surg. 2021 Aug;11(8):3749-3766